CHATSWORTH, Calif., March 30, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), announced today that it is preparing five new patent applications on its unique technology. The Company has engaged New York-based intellectual property experts, Pryor Cashman, to handle the writing and application process. The new patents would boost Provision’s intellectual property protection in the U.S. and ultimately through the international PCT (Patent Cooperation Treaty) process recognized by countries around the world.
“These five patent applications will provide critical protection for our technology and our extended product line, while we transform the POP digital media marketplace in the U.S.,” said Curt Thornton, President and CEO of Provision. “We expect to file additional patent applications this year in advance of our planned expansion into other markets such as video gaming, home entertainment, medical imaging and telecommunications. We know our technology is unique and valuable, so are taking these aggressive steps to protect the Company, its intellectual property as well as its partners and customers worldwide.”
The Company’s technology was recently featured in a solution brief, “Tomorrow’s Digital Signage, Today with 3D Holographic Kiosks” published by Intel.
About Provision Interactive Technologies, Inc.
Provision Interactive Technologies, Inc., a subsidiary of the publicly traded company Provision Holding, Inc. (OTCQB: PVHO), is the leading purveyor of intelligent interactive 3D holographic display technologies, software, and integrated solutions for both commercial and consumer focused applications.
Provision's 3D holographic display systems represent a revolutionary technology that provides the projection of full color, high-resolution videos into space detached from the screen, without any special glasses. Provision is currently the market leader in true 3D consumer advertising display products being implemented by innovative, consumer-focused companies.
Provision Holding, Inc. (OTCQB:PVHO) trades on the OTCQB venture stage marketplace for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com.
For more information, visit www.provision.tv.
Forward-Looking Statements
This press release contains projections of future results and other forward-looking statements that involve a number of risks and uncertainties. Important factors that may cause actual results and outcomes to differ materially from those contained in the projections and forward-looking statements included in this press release are described in our publicly filed reports. Factors that could cause these differences include, but are not limited to, the acceptance of our products, lack of revenue growth, failure to realize profitability, inability to raise capital and market conditions that negatively affect the market price of our common stock. The Company disclaims any responsibility to update any forward-looking statements unless legally required.
CONTACT Media Relations The Lexicomm Group Wendi Tush (212) 794-4531 [email protected]


Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 



